Waiver of the WTO’s Intellectual Property Rules: “Third Way” Is the Same Old Way, Rebranded… March 29, 2021
Backgrounder: WTO-Required Monopolies for Pharmaceutical Corporations Obstruct Global Production of COVID-19 Vaccines & Treatment March 1, 2021
How Overreaching “Trade” Pact Rules Can Undermine Buy American and Other Domestic Preference Procurement Policies February 10, 2021
Table of Foreign Investor-State Cases and Claims Under NAFTA and Other U.S. “Trade Deals” January 15, 2021
Transition Memo on Trade Policy: Biden Trade Policy Must Promote, Not Undermine Build Back Better Goals January 14, 2021
Status of Mexican Protection Unions’ Judicial Challenges Against Mexico’s Labor Law Reform as Revised NAFTA Goes Into Effect June 29, 2020
China Is the Top Source of U.S. Pharmaceutical Imports, With India and Mexico Also Major Sources April 7, 2020
Despite USMCA Spotlight, Significant Shortfall in Mexican Budget for Labor Reform Continues, Mexican Labor Rights Deteriorating November 22, 2019